105AD7 antibody

Also Known As:

antibody 105AD7

Networked: 7 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Anti-Idiotypic Antibodies: 1368
        105AD7 antibody: 7
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Anti-Idiotypic Antibodies: 1368
        105AD7 antibody: 7
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Anti-Idiotypic Antibodies: 1368
        105AD7 antibody: 7

Experts

1.	Durrant, L G: 3 articles (08/2008 - 02/2000)
2.	Kallmeyer, C: 1 article (08/2008)
3.	Pritchard-Jones, K: 1 article (08/2008)
4.	Spendlove, I: 1 article (08/2008)
5.	Ullenhag, G J: 1 article (08/2008)
6.	Watson, N F S: 1 article (08/2008)
7.	Dube, Mukul: 1 article (12/2006)
8.	Durrant, Lindy G: 1 article (12/2006)
9.	Indar, Adrian A: 1 article (12/2006)
10.	Maxwell-Armstrong, Charles: 1 article (12/2006)

Related Diseases

1.	Colorectal Neoplasms (Colorectal Cancer) 12/15/2006 - "A neoadjuvant/adjuvant randomized trial of colorectal cancer patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55." 02/01/2000 - "A neoadjuvant clinical trial in colorectal cancer patients of the human anti-idiotypic antibody 105AD7, which mimics CD55." 12/15/2006 - "Colorectal cancer patients (n = 67) eligible for primary surgery were randomized to receive the anti-idiotypic antibody 105AD7+/-Bacillus Calmette-Guerin/alum or to no treatment (control group). " 01/01/1995 - "A human monoclonal anti-idiotypic antibody, 105AD7, which mimics a colorectal tumor associated antigen, 791Tgp72, has been developed. " 10/01/2000 - "The human anti-idiotypic antibody 105AD7 was isolated from a colorectal cancer patient receiving the anti-tumor antibody 791T/36 for radioimmuno-scintigraphy of liver metastases. "
2.	Neoplasms (Cancer) 01/01/1995 - "Clinical evidence that the human monoclonal anti-idiotypic antibody 105AD7, delays tumor growth by stimulating anti-tumor T-cell responses." 09/15/1994 - "Enhanced cell-mediated tumor killing in patients immunized with human monoclonal antiidiotypic antibody 105AD7." 09/04/1991 - "These findings show that the human monoclonal anti-idiotypic antibody 105AD7 is likely to induce cellular immune responses to tumors in cancer patients." 10/01/2000 - "The human anti-idiotypic antibody 105AD7 was isolated from a colorectal cancer patient receiving the anti-tumor antibody 791T/36 for radioimmuno-scintigraphy of liver metastases. "
3.	Osteosarcoma (Osteogenic Sarcoma) 08/01/2008 - "T-cell responses in osteosarcoma patients vaccinated with an anti-idiotypic antibody, 105AD7, mimicking CD55."
4.	Neoplasm Metastasis (Metastasis) 10/01/2000 - "The human anti-idiotypic antibody 105AD7 was isolated from a colorectal cancer patient receiving the anti-tumor antibody 791T/36 for radioimmuno-scintigraphy of liver metastases. "

Related Drugs and Biologics

1.	Antigens
2.	aluminum sulfate (alum)